Center-Authored Papers
Filters: Author is Moore, Kathleen N [Clear All Filters]
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer.. Cancer chemotherapy and pharmacology. Abstract
.
2015.
Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors.. Investigational new drugs. 34(3):290-299. Abstract
.
2016. Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)